Applying ecological and evolutionary theory to cancer: A long and winding road

Evolutionary Applications

Volumn 6, Issue 1, 2013, Pages 1-10

  Thomas, Frédéric ^a,b   Fisher, Daniel ^b,c,d   Fort, Philippe ^b,d,e   Marie, Jean Pierre ^f   Daoust, Simon ^a   Roche, Benjamin ^b,g   Grunau, Christoph ^a,h   Cosseau, Céline ^a,h   Mitta, Guillaume ^a,h   Baghdiguian, Stephen ^a,d   Rousset, François ^a,d   Lassus, Patrice ^b,c,d   Assenat, Eric ^c,d   Grégoire, Damien ^c,d   Missé, Dorothée ^a   Lorz, Alexander ⁱ   Billy, Frédérique ⁱ   Vainchenker, William ^j   Delhommeau, François ^k,l   Koscielny, Serge ^j   Itzykson, Raphael ^j   Tang, Ruoping ^f   Fava, Fanny ^f   Ballesta, Annabelle ⁱ   Lepoutre, Thomas ^m   Krasinska, Liliana ^c,d   Dulic, Vjekoslav ^c,d   Raynaud, Peggy ^d,e   Blache, Philippe ^d,e   Quittau Prevostel, Corinne ^d,e   Vignal, Emmanuel ^d,e   Trauchessec, Hélène ^d,e   Perthame, Benoit ⁱ   Clairambault, Jean ⁱ   Volpert, Vitali ^m   Solary, Eric ^j   Hibner, Urszula ^b,c,d   Hochberg, Michael E ^a,b,d,n   more..

^a CNRS   (France)

^b Universite de Montpellier   (France)

^c INSTITUT DE GÉNÉTIQUE MOLÉCULAIRE DE MONTPELLIER   (France)

^d UNIV MONTPELLIER   (France)

^e Centre National de la Recherche Scientifique   (France)

^f ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^g Université Pierre et Marie Curie   (France)

^h UPVD Perpignan   (France)

ⁱ UNIVERSITÉ PIERRE ET MARIE CURIE   (France)

^j INSERM   (France)

^k SORBONNE UNIVERSITÉ   (France)

^l HÔPITAL SAINT ANTOINE   (France)

^m UNIVERSITÉ LYON 1   (France)

ⁿ SANTA FE INSTITUTE   (United States)

more..

Author keywords

Cancer, disease biology; Evolutionary medicine; Evolutionary theory

Indexed keywords

EID: 84872759734     PISSN: 17524563     EISSN: 17524571     Source Type: Journal    
DOI: 10.1111/eva.12021     Document Type: Article

References (108)

1. Aktipis, C. A., V. S. Kwan, K. A. Johnson, S. L. Neuberg, and C. C. Maley 2011. Overlooking evolution: a systematic analysis of cancer relapse and therapeutic resistance research. PLoS ONE 6:e26100.
2. Anderson, A. R., A. M. Weaver, and V. Quaranta 2006. Tumor morphology and phenotypic evolution driven by selective pressure from the microenvironment. Cell 127:905-915.
3. Balducci, L., and W. B. Ershler 2005. Cancer and ageing: a nexus at several levels. Nature Review Cancer 5:655-662.
4. Bissell, M. J., and W. C. Hines 2011. Why don't we get more cancer? A proposed role of the microenvironment in restraining cancer progression. Nature Medicine 17:320-329.
5. Bozic, I., T. Antal, H. Ohtsuki, H. Carter, D. Kim, S. Chen, R. Karchin et al. 2010. Accumulation of driver and passenger mutations during tumor progression. Proceedings of the National Academy of Sciences of the United States of America 107:18545-18550.
6. Byrne, H. M. 2010. Using mathematics to dissect cancer. Nature Reviews Cancer 10:221-230.
7. Byrne, H. M., and D. Drasdo 2009. Individual-based and continuum models of growing cell populations: a comparison. Journal of Mathematical Biology 58:657-687.
8. Cahill, D. P., K. W. Kinzler, B. Vogelstein, and C. Lengauer 1999. Genetic instability and Darwinian selection in tumours. Trends in Cell Biology 9:M57-M60.
9. Cairns, J. 1975. Mutation selection and the natural history of cancer. Nature 255:197-200.
10. Cancer Genome Atlas Network. 2012. Comprehensive molecular characterization of human colon and rectal cancer. Nature, 487:330-337.
11. Caulin, A. F., and C. C. Maley 2011. Peto's paradox: evolution's prescription for cancer prevention. Trends in Ecology and Evolution 26:175-182.
12. Cooperberg, M. R., P. R. Carroll, and L. Klotz 2011. Active surveillance for prostate cancer: progress and promise. Journal of Clinical Oncology 29:3669-3676.
13. Crespi, B., and K. Summers 2006. Positive selection in the evolution of cancer. Biological Review 81:407-424.
14. Cunningham, J. J., R. A. Gatenby, and J. S. Brown 2011. Evolutionary dynamics in cancer therapy. Molecular Pharmacology 8:2094-2100.
15. Dapito, D. H., A. Mencin, G. Y. Gwak, J. P. Pradere, M. K. Jang, I. Mederacke, J. M. Caviglia et al. 2012. Promotion of hepatocellular carcinoma by the intestinal Microbiota and TLR4. Cancer Cell 21:504-516.
16. De Martel, C., and S. Franceschi 2009. Infections and cancer: established associations and new hypotheses. Critical Reviews in Oncology and Haematology 70:183-194.
17. Dingli, D., A. Traulsen, and F. Michor 2007. Symmetric stem cell replication and cancer. PLoS Computational Biology 3:e53.
18. Drake, N. 2011. Forty years on from Nixon's war, cancer research 'evolves'. Nature Medicine 17:757.
19. Egeblad, M., M. G. Rasch, and V. M. Weaver 2010. Dynamic interplay between the collagen scaffold and tumor evolution. Current Opinion in Cell Biology 22:697-706.
20. Epstein, S. S., R. Bertell, and B. Seaman 2001. Dangers and unreliability of mammography: breast examination is a safe, effective, and practical alternative. International Journal of Health Services 31:605-615.
21. Ewald, P. W. 2009 An evolutionary perspective on parasitism as a cause of cancer? Advances in Parasitology 68:21-43.
22. Fernandez, A. A., and P. R. Bowser 2010. Selection for a dominant oncogene and lage male size as a risk factor for melanoma in the Xiphophorus animal model. Molecular Ecology 19:3114-3123.
23. Fitzpatrick, F. A. 2001. Inflammation, carcinogenesis and cancer. International Immunopharmacology 11:1651-1667.
24. Folkman, J., and R. Kalluri 2004. Cancer without disease. Nature 427:787.
25. Foo, J., and F. Michor 2009. Evolution of resistance to targeted anti-cancer therapies during continuous and pulsed administration strategies. PLoS Computational Biology 11:e1000557.
26. Frank, S. A. 2004. Age-specific acceleration of cancer. Current Biology 14:242-246.
27. Frank, S. A. 2005. Age-specific incidence of inherited versus sporadic cancers: a test of the multistage theory of carcinogenesis. Proceedings of the National Academy of Sciences of the United States of America 102:1071-1075.
28. Fridriksdottir, A. J. R., O. W. Petersen, and L. Rønnov-Jessen 2011. Mammary gland stem cells: current status and future challenges. The International Journal of Developmental Biology 55:719-729.
29. Frieboes, H. B., X. Zheng, C.-H. Sun, B. Tromberg, R. Gatenby, and V. Cristini 2006. An integrated computational/experimental model of tumor invasion. Cancer Research 66:1597-1604.
30. Frieboes, H. B., M. E. Edgerton, J. P. Fruehauf, F. R. Rose, L. K. Worrall, R. A. Gatenby, M. Ferrari et al. 2009. Prediction of drug response in breast cancer using integrative experimental/computational modeling. Cancer Research 69:4484-4492.
31. Gatenby, R. A. 2011. Of cancer and cave fish. Nature Review Cancer 11:237-238.
32. Gatenby, R. A., and T. L. Vincent 2003. An evolutionary model of carcinogenesis. Cancer Research 63:6212-6220.
33. Gatenby, R. A., E. T. Gawlinski, A. F. Gmitro, B. Kaylor, and R. J. Gillies 2006. Acid-mediated tumor invasion: a multidisciplinary study. Cancer Research 66:5216.
34. Gatenby, R. A., A. S. Silva, R. J. Gillies, and B. R. Frieden 2009. Adaptive therapy. Cancer Research 69:4894-4903.
35. Gerlinger, M., and C. Swanton 2010. How Darwinian models inform therapeutic failure initiated by clonal heterogeneity in cancer medicine. British Journal of Cancer 103:1139-1143.
36. Gerlinger, M., A. J. Rowan, S. Horswell, J. Larkin, D. Endesfelder, E. Gronroos, P. Martinez et al. 2012. Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. The New England Journal of Medicine 366:883-892.
37. Gibbons, D. L., S. Pricl, H. Kantarjian, J. Cortes, and A. Quintás-Cardama 2012. The rise and fall of gatekeeper mutations? The BCR-ABL1 T315I paradigm. Cancer 118:293-299.
38. Gillies, R. J., D. Verduzco, and R. A. Gatenby 2012. Evolutionary dynamics of carcinogenesis and why targeted therapy does not work. Nature Reviews Cancer 12:487-493.
39. Gorbunova, V., and A. Seluanov 2009. Coevolution of telomerase activity and body mass in mammals: from mice to beavers. Mechanisms of Ageing and Development 130:3-9.
40. Greaves, M., and C. C. Maley 2012. Clonal evolution in cancer. Nature 481:306-313.
41. Green, D. R., T. Ferguson, L. Zitvogel, and G. Kroemer 2009. Immunogenic and tolerogenic cell death. Nature Review Immunology 9:353-363.
42. Hanahan, D., and R. A. Weinberg 2011. Hallmarks of cancer: the next generation. Cell 144:646-674.
43. zur Hausen, H. Z. 2009. The search for infectious causes of human cancers: where and why (Nobel lecture). Angewandte Chemie International Edition 48:5798-5808.
44. Huang, Q., F. Li, X. Liu, W. Li, W. Shi, F. F. Liu, B. O'Sullivan et al. 2011. Caspase 3-mediated stimulation of tumor cell repopulation during cancer radiotherapy. Nature Medicine 17:860-866.
45. International network of cancer genome projects. Nature 464:993-998.
46. Iwami, S., H. Haeno, and F. Michor 2012. A race between tumor immunoescape and genome maintenance selects for optimum levels of (epi)genetic instability. PLoS Computational Biology 8:e1002370.
47. Iwasa, Y., M. A. Nowak, and F. Michor 2006. Evolution of resistance during clonal expansion. Genetics 172:2557-2566.
48. Komarova, N. L., and D. Wodarz 2005. Drug resistance in cancer: principles of emergence and prevention. Proceedings of the National Academy of Sciences of the United States of America 102:9714-9719.
49. Leary, R. J., J. C. Lin, J. Cummins, S. Boca, L. D. Wood, D. W. Parsons, S. Jones et al. 2008. Integrated analysis of homozygous deletions, focal amplifications, and sequence alterations in breast and colorectal cancers. Proceedings of the National Academy of Sciences of the United States of America 105:16224-16229.
50. Lee, H. O., A. S. Silva, S. Concilio, Y. S. Li, M. Slifker, R. A. Gatenby, and J. D. Cheng 2011. Evolution of tumor invasiveness: the adaptive tumor microenvironment landscape model. Cancer Research 20:6327-6337.
51. van Leeuwen, I. M. M., C. M. Edwards, M. Ilyas, and H. M. Byrne 2007. Towards a multiscale model of colorectal cancer. World Journal of Gastroenterology: WJG 13:1399-1407.
52. Lorz, A., T. Lorenzi, M. E. Hochberg, J. Clairambault, and B. Perthame 2012. Populational adaptive evolution, chemotherapeutic resistance and multiple anti-cancer therapies. Mathematical Modelling and Numerical Analysis, http://hal.archives-ouvertes.fr/hal-00714274.
53. Ma, Q. C., C. A. Ennis, and S. Aparicio 2012. Opening Pandora's Box - the new biology of driver mutations and clonal evolution in cancer as revealed by next generation sequencing. Current Opinion in Genetics and Development 22:3-9.
54. Maley, C. C., P. C. Galipeau, J. C. Finley, V. J. Wongsurawat, X. Li, C. A. Sanchez, T. G. Paulson et al. 2006. Genetic clonal diversity predicts progression to esophageal adenocarcinoma. Nature Genetics 38:468-473.
55. Mani, S. A., W. Guo, M. J. Liao, E. N. Eaton, A. Ayyanan, A. Y. Zhou, M. Brooks et al. 2008. The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 133:704-715.
56. Martinez-Quintanilla, J., M. Cascallo, C. Fillat, and R. Alemany 2009. Antitumor therapy based on cellular competition. Human Gene Therapy 20:728-738.
57. Marusyk, A., and K. Polyak 2010. Tumor heterogeneity: causes and consequences. Biochimica et Biophysica Acta (BBA). Reviews on Cancer 1805:105-117.
58. Marusyk, A., V. Almendro, and K. Polyak 2012. Intra-tumour heterogeneity: a looking glass for cancer? Nature Reviews Cancer 12:323-334.
59. Marzac, C., E. Garrido, R. Tang, F. Fava, P. Hirsch, C. De Benedictis, S. Lapusan et al. 2011. ABC transporters associated with chemoresistance: transcriptional profiling in extreme cohorts, and their prognostic impact in a cohort of 281 AML patients. Haematologica 96:1293-1301.
60. Merlo, L. M. F., and C. C. Maley 2010. The role of genetic diversity in cancer. Journal of Clinical Investigation 120:401-403.
61. Merlo, L. M., J. W. Pepper, B. J. Reid, and C. C. Maley 2006. Cancer as an evolutionary and ecological process. Nature Reviews Cancer 6:924-935.
62. Michor, F. 2008. Mathematical models of cancer stem cells. Journal of Clinical Oncology 26:2854-2861.
63. Michor, F., T. P. Hughes, Y. Iwasa, S. Branford, N. P. Shah, C. L. Sawyers, and M. A. Nowak 2005. Dynamics of chronic myeloid leukemia. Nature 435:1267-1270.
64. Michor, F., M. A. Nowak, and Y. Iwasa 2006. Stochastic dynamics of metastasis formation. Journal of Theoretical Biology 240:521-530.
65. Miller, B. E., F. R. Miller, D. Wilburn, and G. H. Heppner 1988. Dominance of a tumour subpopulation line in mixed heterogeneous mouse mammary tumours. Cancer Research 48:5747-5753.
66. Morel, A. P., M. Lièvre, C. Thomas, G. Hinkal, S. Ansieau, and A. Puisieux 2008. Generation of breast cancer stem cells through epithelial-mesenchymal transition. PLoS ONE 3:e2888.
67. Navin, N., A. Krasnitz, L. Rodgers, K. Cook, J. Meth, J. Kendall, M. Riggs et al. 2010. Inferring tumor progression from genomic heterogeneity. Genome Research 20:68-80.
68. Navin, N., J. Kendall, J. Troge, P. Andrews, L. Rodgers, J. McIndoo, K. Cook et al. 2011. Tumour evolution inferred by single-cell sequencing. Nature 472:90-95.
69. Nowell, P. C. 1976. The clonal evolution of tumour cell populations. Science 194:23-28.
70. Oertel, M., A. Menthena, M. D. Dabeva, and D. A. Shafritz 2006. Cell competition leads to a high level of normal liver reconstitution by transplanted fetal liver stem/progenitor cells. Gastroenterology 130:507-520.
71. Osborne, J. M., A. Walter, S. K. Kershaw, G. R. Mirams, A. G. Fletcher, P. Pathmanathan, D. Gavaghan et al. 2010. A hybrid approach to multi-scale modelling of cancer. Philosophical Transactions of the Royal Society A Mathematical, Physical and Engineering Sciences 368:5013-5028.
72. Parmigiani, G., S. Boca, J. Lin, K. W. Kinzler, V. Velculescu, and B. Vogelstein 2009. Design and analysis issues in genome-wide mutation analysis studies of cancer. Genomics 93:17-21.
73. Peto, R., F. J. Roe, P. N. Lee, L. Levy, and J. Clack 1975. Cancer and ageing in mice and men. British Journal of Cancer 32:411-426.
74. Pienta, K. J., N. M. C. McGregor, R. Axelrod, and D. E. Axelrod 2008. Ecological therapy for cancer: defining tumors using an ecosystem paradigm suggests new opportunities for novel cancer treatments. Translational Oncology 4:158-164.
75. Polyak, K., I. Haviv, and I. G. Campbell 2009. Co-evolution of tumor cells and their microenvironment. Trends in Genetics 25:30-38.
76. Riegman, P. H., and E. B. van Veen 2011. Biobanking residual tissues. Human Genetics 130:357-368.
77. Riester, M., C. Stephan-Otto Attolini, R. J. Downey, S. Singer, and F. Michor 2010. A differentiation-based phylogeny of cancer subtypes. PLoS Computational Biology 6:e1000777.
78. Roche, B., M. E. Hochberg, A. F. Caulin, C. C. Maley, R. A. Gatenby, D. Missé, and F. Thomas (in press) Natural resistance to cancers: a Darwinian hypothesis to explain Peto's paradox. BMC Cancer.
79. Romanov, G. A., and B. F. Vanyushin 1981. Methylation of reiterated sequences in mammalian DNAs. Effects of the tissue type, age, malignancy and hormonal induction. Biochimica et Biophysica Acta 653:204-218.
80. Seluanov, A., C. Hine, M. Bozzella, A. Hall, T. H. C. Sasahara, A. A. C. M. Ribeiro, K. C. Catania et al. 2008. Distinct tumor suppressor mechanisms evolve in rodent species that differ in size and lifespan. Aging Cell 7:813-823.
81. Shipitsin, M., and K. Polyak 2008. The cancer stem cell hypothesis: in search of definitions, markers and relevance. Laboratory Investigation 88:459-463.
82. Sjöblom, T., S. Jones, L. D. Wood, D. W. Parsons, J. Lin, T. D. Barber, D. Mandelker et al. 2006. The consensus coding sequences of human breast and colorectal cancers. Science 314:268-274.
83. Smith, K. R., H. A. Hanson, G. P. Mineau, and S. S. Buys 2012. Effects of BRCA1 and BRCA2 mutations on female fertility. Proceedings of the Royal Society of London Series B-Biological Sciences 279:2926-2929.
84. Solé, R. V., and T. S. Deisboeck 2004. An error catastrophe in cancer? Journal of Theoretical Biology 228:47-54.
85. Sottoriva, A., L. Vermeulen, and S. Tavaré 2011. Modeling evolutionary dynamics of epigenetic mutations in hierarchically organized tumors. PLoS Computational Biology 7:e1001132.
86. Sprouffske, K., J. W. Pepper, and C. C. Maley 2011. Accurate reconstruction of the temporal order of mutations in neoplastic progression. Cancer Prevention Research 4:1135-1144.
87. Stephan-Otto Attolini, C., Y.-K. Cheng, R. Beroukhim, G. Getz, O. Abdel-Wahab, R. L. Levine, I. K. Mellinghoff et al. 2010. A mathematical framework to determine the temporal sequence of somatic genetic events in cancer. Proceedings of the National Academy of Sciences of the United States of America 107:17604-17609.
88. Stephens, P. J., C. D. Greenman, B. Fu, F. Yang, G. R. Bignell, L. J. Mudie, E. D. Pleasance et al. 2011. Massive genomic rearrangement acquired in a single catastrophic event during cancer development. Cell 144:27-40.
89. Subramanian, A., S. Shackney, and R. Schwartz 2012. Inference of tumor phylogenies from genomic assays on heterogeneous samples. Journal of Biomedicine and Biotechnology. doi: 10.1155/2012/797812.
90. Summers, K., and B. Crespi 2008. The androgen receptor and prostate cancer: a role for sexual selection and sexual conflict? Medical Hypotheses 70:435-443.
91. Summers, K., and B. J. Crespi 2010. Xmrks the spot: life history tradeoffs, sexual selection and the evolutionary ecology of oncogenesis. Molecular Ecology 19:3022-3024.
92. Takahashi, K., and S. Yamanaka 2006. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126:663-676.
93. Tamori, Y., C. U. Bialucha, A.-G. Tian, M. Kajita, Y.-C. Huang, M. Norman, N. Harrison et al. 2010. Involvement of Lgl and Mahjong/VprBP in cell competition. PLoS Biology 8:e1000422.
94. Tang, R., P. Hirsch, F. Fava, S. Lapusan, C. Marzac, I. Teyssandier, J. Pardo et al. 2009. High Id1 expression is associated with poor prognosis in 237 patients with acute myeloid leukemia. Blood 114:2993-3000.
95. Tarafa, G., E. Prat, R. A. Risques, S. Gonzalez, J. Camps, M. Grau, E. Guino et al. 2003. Common genetic evolutionary pathways in familial adenomatous polyposis tumors. Cancer Research 63:5731-5737.
96. Thomas, F., E. Elguero, J. Brodeur, J. Le Goff, and D. Missé 2011. Herpes simplex virus type 2 and cancer: a medical geography approach. Infection, Genetics and Evolution 11:1239-1242.
97. Thomas, F., K. D. Lafferty, J. Brodeur, E. Elguero, M. Gauthier-Clerc, and D. Missé 2012a. Incidence of adult brain cancers is higher in countries where the protozoan parasite Toxoplasma gondii is common. Biology Letters 8:101-103.
98. Thomas, F., E. Elguero, J. Brodeur, D. Missé, and M. Raymond 2012b. Malignancies and high birthweight in human: which cancers could result from antagonistic pleiotropy? Journal of Evolutionary Medicine 1:5.
99. Tomasetti, C., and D. Levy 2010. An elementary approach to modeling drug resistance in cancer. Mathematical Biosciences and Engineering 7:905-918.
100. Tomlinson, I., and W. Bodmer 1999. Selection, the mutation rate and cancer: ensuring that the tail does not wag the dog. Nature Medicine 5:11-12.
101. Vainchenker, W., F. Delhommeau, S. N. Constantinescu, and O. A. Bernard 2011. New mutations and pathogenesis of myeloproliferative neoplasms. Blood 118:1723-1735.
102. Valastyan, S., and R. A. Weinberg 2011. Tumor metastasis: molecular insights and evolving paradigms. Cell 147:275-292.
103. Vineis, P., and M. Berwick 2006. The population dynamics of cancer: a Darwinian perspective. International Journal of Epidemiology 35:1151-1159.
104. Visvader, J. E., and G. J. Lindeman 2008. Cancer stem cells in solid tumours: accumulating evidence and unresolved questions. Nature Reviews Cancer 8:755-768.
105. Vittecoq, M., E. Elguero, K. D. Lafferty, B. Roche, J. Brodeur, M. Gauthier-Clerc, D. Missé et al. 2012. Brain cancer mortality rates increase with Toxoplasma gondii seroprevalence in France. Infection, Genetics and Evolution 12:496-498.
106. Wood, L. D., D. W. Parsons, S. Jones, J. Lin, T. Sjoblom, R. Leary, D. Shen et al. 2007. The genomic landscapes of human breast and colorectal cancers. Science 318:1108-1113.
107. World Health Organization. (2008). Cancer fact sheet number 297. Available online at: http://www.who.int/mediacentre/factsheets/fs297/en/index.html (accessed on 20 November 2008).
108. Zender, L., M. S. Spector, W. Xue, P. Flemming, C. Cordon-Cardo, J. Silke, S. T. Fan et al. 2006. Identification and validation of oncogenes in liver cancer using an integrative oncogenomic approach. Cell 125:1253-1267.